NOVT: Novanta Company Sales Revenue

Local environmental energy-saving and toxin control measures support asset stability, as confirmed by Novanta Inc. (NOVT) aggregate trading revenue. The current level of this metric is 1.09. The financial result is based on B2B supplies of OEM components for robotics and medicine, while operational resilience is ensured by a strategic combination of external sourcing for basic optics and high-precision in-house assembly.

Revenue and Sales Volume: Novanta (NOVT) for 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Novanta Photonics (NOVT)

- stock value and consensus price forecast:

Stock Quotes Novanta|NOVT - Consensus Target

- market capitalization information:

Market Value Novanta Corp|NOVT - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Novanta|NOVT - Book Capitalization|Market-to-Book Ratio novanta.com|NOVT - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

NOVT - Net Income|Expected Net Income Novanta Inc.|NOVT - P/E Multiple|Projected Price to Earnings Ratio Novanta Inc|NOVT - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Novanta Photonics|NOVT - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Novanta|NOVT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months novanta.com|NOVT - Earnings per share growth in current year|Net earnings per share change forecast for next year Novanta Inc.

- company sales and revenue statistics:

NOVT - Company Revenue|Company Future Sales Volume Novanta Inc.|NOVT - P/S Multiple|Market Cap to Future Revenue Ratio Novanta Corp|NOVT - Sales Growth YoY (Last Twelve Months)

Summary company analysis:NOVT Novanta Inc.

Operating revenue measures the aggregate cash flow from core activities, allowing investors to distinguish a temporary asset undervaluation from a systemic business decline. Analyzing the sales time series of Novanta Inc. confirms the financial stability of Novanta Inc., whose deep integration into the production of specialized medical laser systems minimizes the risk of customer churn due to the complexity of replacing customized components.

Key competitors